 CAMBRIDGE, Mass., April 11, 2021 PRNewswire -- Blueprint Medicines Corporation NASDAQ: BPMC today announced that multiple presentations across the companys leading systemic mastocytosis SM program are being reported at the virtual American Association for Cancer Research AACR Annual Meeting 2021. 